Leukemia Research
Volume 30, Issue 9 , Pages 1105-1112 , September 2006

Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia

  • Jun Taguchi

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Yasushi Miyazaki

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 95 849 7111; fax: +81 95 849 7113.
    • ,
  • Chizuko Tsutsumi

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Yasushi Sawayama

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Koji Ando

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Hideki Tsushima

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Takuya Fukushima

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Tomoko Hata

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Shinichiro Yoshida

      Affiliations

    • Department of Internal Medicine, Nagasaki National Medical Center, 2-1001-1 Ohmura, Nagasaki 856-8562, Japan
    • ,
  • Kazutaka Kuriyama

      Affiliations

    • School of Health Sciences, University of the Ryukyus, Nishihara, Okinawa 903-0215, Japan
    • ,
  • Sumihisa Honda

      Affiliations

    • Department of Radiation Epidemiology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Itsuro Jinnai

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
    • ,
  • Hiroyuki Mano

      Affiliations

    • Divisions of Functional Genomics, Jichi Medical School, 3311-1 Minamikawachi-machi Yakushiji, Kawachi-gun, Tochigi 329-0498, Japan
    • ,
  • Masao Tomonaga

      Affiliations

    • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan

Received 15 October 2005 ,Revised 30 December 2005 ,Accepted 30 December 2005.

References 

  1. Babior BM. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med. 1978;298:659–668
  2. Babior BM. Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med. 1978;298:721–725
  3. Koeffler HP, Ranyard J, Pertcheck M. Myeloperoxidase: its structure and expression during myeloid differentiation. Blood. 1985;65:484–491
  4. Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol. 2000;7:53–58
  5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French–American–British Cooperative Group. Ann Intern Med. 1985;103:620–629
  6. Hoyle CF, Gray RG, Wheatley K, Swirsky D, de Bastos M, Sherrington P, et al. Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1386 patients with de novo acute myeloid leukaemia. Br J Haematol. 1991;79:398–407
  7. Matsuo T, Cox C, Bennett JM. Prognostic significance of myeloperoxidase positivity of blast cells in acute myeloblastic leukemia without maturation (FAB: M1): an ECOG study. Hematol Pathol. 1989;3:153–158
  8. Matsuo T, Kuriyama K, Miyazaki Y, Yoshida S, Tomonaga M, Emi N, et al. The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype. Leukemia. 2003;17:1538–1543
  9. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90:5002–5012
  10. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1997;90:5013–5021
  11. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–737
  12. de Wynter EA, Buck D, Hart C, Heywood R, Coutinho LH, Clayton A, et al. CD34+ AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells. 1998;16:387–396
  13. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038–1045
  14. Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M. Isolation and characterization of human CD34(−)Lin(−) and CD34(+)Lin(−) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood. 2000;95:2813–2820
  15. Shmelkov SV, Jun L, St Clair R, McGarrigie D, Derderian CA, Usenko JK, et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood. 2004;103:2055–2061
  16. Ohmine K, Ota J, Ueda M, Ueno S, Yoshida K, Yamashita Y, et al. Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells. Oncogene. 2001;20:8249–8257
  17. Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukaemia. Proc Natl Acad Sci USA. 2002;99:14925–14930
  18. Tsutsumi C, Ueda M, Miyazaki Y, Yamashita Y, Choi YL, Ota J, et al. DNA microarray analysis of dysplastic morphology associated with acute myeloid leukemia. Exp Hematol. 2004;32:828–835
  19. Kuriyama K, Tomonaga M, Matsuo T, Kobayashi T, Miwa H, Shirakawa S, et al. Japan Adult Leukaemia Study Group (JALSG) Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol. 1994;86:767–773
  20. Gabert J, Beillard E, van der Velden VHJ, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukaemia—A Europe Against Cancer Program. Luekemia. 2003;17:2318–2357
  21. Shibata A, Bennett JM, Castoldi GL, Catovsky D, Flandrin G, Jaffe ES, et al. Recommended methods for cytological procedures in haematology. International Committee for Standardization in Haematology (ICSH). Clin Lab Haematol. 1985;7:55–74
  22. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92:2322–2333
  23. Miyazaki Y, Kuriyama K, Miyawaki S, Ohtake S, Sakamaki H, Matsuo T, et al. Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study. Br J Haematol. 2003;120:56–62
  24. Vercauteren SM, Sutherland HJ. CD133 (AC133) expression on AML cells and progenitors. Cytotherapy. 2001;3:449–459
  25. Fauth F, Weidmann E, Martin H, Schneider B, Sonnhoff S, Hoelzer D. AC133 expression on acute myeloid leukemia blasts: correlation to FAB and to CD34 expression and possible implications for peripheral blood progenitor cell purging in AML. Leuk Res. 2001;25:191–196
  26. Kuci S, Wessels JT, Buhring HJ, Schilbach K, Schumm M, Seitz G, et al. Identification of a novel class of human adherent CD34-stem cells that give rise to SCID-repopulating cells. Blood. 2003;101:869–876
  27. Koehl U, Zimmermann S, Esser R, Sorensen J, Gruttner HP, Duchscherer M, et al. Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia. Bone Marrow Transplant. 2002;29:927–930
  28. Zaki SR, Austin GE, Swan D, Srinivasan A, Ragab AH, Chan WC. Human myeloperoxidase gene expression in acute leukemia. Blood. 1989;74:2096–2102
  29. Chang KS, Trujillo JM, Cook RG, Stass SA. Human myeloperoxidase gene: molecular cloning and expression in leukemic cells. Blood. 1986;68:1411–1414
  30. Austin GE, Chan WC, Zhao W, Racine M. Myeloperoxidase gene expression in normal granulopoiesis and acute leukemias. Leuk Lymphoma. 1994;15:209–220
  31. Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C, et al. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 1997;11:774–785
  32. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193–197
  33. Ye M, Iwasaki H, Laiosa CV, Stadtfeld M, Xie H, Heck S, et al. Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity. 2003;19:689–699
  34. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341:1051–1062

PII: S0145-2126(06)00005-1

doi: 10.1016/j.leukres.2005.12.012

Leukemia Research
Volume 30, Issue 9 , Pages 1105-1112 , September 2006

Article Tools

* Image Usage & Resolution